1.With the highest number of clinical cases globally , its treatment protocols and practical experience far surpass those of Europe and the United States.
China has the highest number of lung cancer diagnoses and treatments globally each year, and its doctors possess the most accurate understanding of the gene mutation characteristics and lesion distribution patterns in Asian lung cancer populations. Given similar conditions, Chinese doctors have far superior experience in handling complex lesions, advanced-stage tumors, and difficult cases with underlying diseases compared to overseas medical institutions with fewer patients, resulting in a higher tolerance for error and a higher surgical success rate.
2.Advanced minimally invasive surgery for precise lung preservation.
We possess extensive practical experience in early diagnosis and treatment of pulmonary nodules, concurrent chemoradiotherapy for locally advanced lung cancer, and second-/third-line salvage therapy for advanced lung cancer after targeted drug resistance. In China , robotic minimally invasive surgery accounts for over 90% of procedures, enabling precise lung-preserving radical treatment with superior postoperative lung function preservation compared to conventional surgeries overseas.
3.Overall costs are significantly lower than in Europe and America, with no hidden fees.
China has widely adopted proton and heavy ion therapy and robotic minimally invasive surgery with no hidden fees, significantly reducing the cost of treating serious illnesses . Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.
4.Zero waiting period, rapid medical intervention to avoid delays in treatment.
In Europe, America, Japan, and South Korea, the waiting time for specialist appointments and surgeries at public hospitals is generally 3-12 months, while private institutions are extremely expensive and still have a waiting period of 1-3 months. China has a well-established international medical channel, and lung cancer patients who come to China for medical tourism through Trisana Medguide can have an in-person consultation within 3 days and start treatment within 7 days, allowing for early admission and early recovery and preventing delays in treatment.

